Alvogen – Recall of fentanyl transdermal system
April 22, 2019 - The FDA announced a voluntary, consumer-level recall of two lots of Alvogen’s fentanyl transdermal system 12 mcg/h transdermal patches because a small number of cartons labeled 12 mcg/h fentanyl transdermal system patches contained 50 mcg/h patches.
Top